Jointown Pharmaceutical Group Co Ltd (600998) - Total Assets

Latest as of September 2025: CN¥112.28 Billion CNY ≈ $16.43 Billion USD

Based on the latest financial reports, Jointown Pharmaceutical Group Co Ltd (600998) holds total assets worth CN¥112.28 Billion CNY (≈ $16.43 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Jointown Pharmaceutical Group Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Jointown Pharmaceutical Group Co Ltd - Total Assets Trend (2007–2024)

This chart illustrates how Jointown Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data.

Jointown Pharmaceutical Group Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Jointown Pharmaceutical Group Co Ltd's total assets of CN¥112.28 Billion consist of 82.3% current assets and 17.8% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	17.0%
Accounts Receivable	CN¥37.37 Billion	36.5%
Inventory	CN¥22.85 Billion	22.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥2.20 Billion	2.2%
Goodwill	CN¥799.37 Million	0.8%

Asset Composition Trend (2007–2024)

This chart illustrates how Jointown Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Jointown Pharmaceutical Group Co Ltd market cap and net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jointown Pharmaceutical Group Co Ltd's current assets represent 82.3% of total assets in 2024, a decrease from 83.0% in 2007.
Cash Position: Cash and equivalents constituted 17.0% of total assets in 2024, down from 25.6% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 3.0% in 2007.
Asset Diversification: The largest asset category is accounts receivable at 36.5% of total assets.

Jointown Pharmaceutical Group Co Ltd Competitors by Total Assets

Key competitors of Jointown Pharmaceutical Group Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Guangxi Liuzhou Pharm Co Ltd SHG:603368	China	CN¥21.18 Billion
Sigma Healthcare Ltd AU:SIG	Australia	AU$8.74 Billion
Ebos Group Ltd AU:EBO	Australia	AU$7.84 Billion
Paragon Care Ltd AU:PGC	Australia	AU$1.31 Billion
Mayne Pharma Group Ltd AU:MYX	Australia	AU$1.01 Billion
Cyclopharm Ltd AU:CYC	Australia	AU$55.91 Million
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Brazil	R$5.64 Billion
Shanghai Pharmaceuticals Holding Co Ltd SHG:601607	China	CN¥233.15 Billion

Jointown Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.24	1.27	1.29
Quick Ratio	0.93	0.98	1.00
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥18.27 Billion	CN¥17.45 Billion	CN¥14.82 Billion

Jointown Pharmaceutical Group Co Ltd - Advanced Valuation Insights

This section examines the relationship between Jointown Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.00
Latest Market Cap to Assets Ratio	0.04
Asset Growth Rate (YoY)	10.4%
Total Assets	CN¥102.40 Billion
Market Capitalization	$3.81 Billion USD

Valuation Analysis

Below Book Valuation: The market values Jointown Pharmaceutical Group Co Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Jointown Pharmaceutical Group Co Ltd's assets grew by 10.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Jointown Pharmaceutical Group Co Ltd (2007–2024)

The table below shows the annual total assets of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥102.40 Billion ≈ $14.98 Billion	+10.35%
2023-12-31	CN¥92.79 Billion ≈ $13.58 Billion	+0.56%
2022-12-31	CN¥92.27 Billion ≈ $13.50 Billion	+7.37%
2021-12-31	CN¥85.94 Billion ≈ $12.58 Billion	+6.32%
2020-12-31	CN¥80.82 Billion ≈ $11.83 Billion	+13.60%
2019-12-31	CN¥71.15 Billion ≈ $10.41 Billion	+6.71%
2018-12-31	CN¥66.67 Billion ≈ $9.76 Billion	+28.10%
2017-12-31	CN¥52.05 Billion ≈ $7.62 Billion	+34.39%
2016-12-31	CN¥38.73 Billion ≈ $5.67 Billion	+18.85%
2015-12-31	CN¥32.58 Billion ≈ $4.77 Billion	+35.07%
2014-12-31	CN¥24.13 Billion ≈ $3.53 Billion	+29.73%
2013-12-31	CN¥18.60 Billion ≈ $2.72 Billion	+25.62%
2012-12-31	CN¥14.80 Billion ≈ $2.17 Billion	+25.05%
2011-12-31	CN¥11.84 Billion ≈ $1.73 Billion	+45.81%
2010-12-31	CN¥8.12 Billion ≈ $1.19 Billion	+13.27%
2009-12-31	CN¥7.17 Billion ≈ $1.05 Billion	+25.33%
2008-12-31	CN¥5.72 Billion ≈ $836.85 Million	+29.27%
2007-12-31	CN¥4.42 Billion ≈ $647.35 Million	--

About Jointown Pharmaceutical Group Co Ltd

SHG:600998 China Medical Distribution

Market Cap

$3.81 Billion

CN¥26.07 Billion CNY

Market Cap Rank

#4268 Global

#749 in China

Share Price

CN¥5.17

Change (1 day)

-0.39%

52-Week Range

CN¥4.85 - CN¥5.60

All Time High

CN¥44.36